The goal of the project is to develop novel immunoassays to improve the diagnosis of dementia with Lewy Bodies.
Your main tasks and responsibilities in this project are:
- To develop customized panels of immunoassays for analysis of novel biomarker candidates;
- Optimize these panels for biomarker detection in both cerebrospinal fluid and blood using state-of-the-art technologies, such as single molecule arrays;
- Technically and clinically validate these novel tests in relevant patient samples from different cohorts;
- To process and to analyse the data;
- To communicate results by means of oral presentations and scientific publications;
- Perform two secondments (internships) of 3 months at the patient organisation Alzheimer Nederland, to organise inventories to learn about patient perspectives towards early diagnosis, and reachout to the public and patients.
We look for excellent candidates with a M.Sc. degree in Biology, Chemistry, or related fields.
The primary host of the project is: Amsterdam UMC location VUmc, The Netherlands
As early stage researcher you work in close collaboration with the head of the research group (Prof. Charlotte Teunissen), postdoc (Dr. Eline Willemse), and second supervisor (Dr. Minke Kooistra). You will be part of a young, multidisciplinary team, with ample experience, and an excellent position within the expert field of biomarker development and patient outreach.